RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 BRIDGE
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 21
SP 6
OP 6
DO 10.1177/1559897715599363
UL http://mdc.sagepub.com/content/15/21/6.1.abstract
AB In the BRIDGE trial, bridging with low molecular weight heparin in patients with atrial fibrillation who underwent surgery or an invasive procedure that required warfarin interruption resulted in similar rates of arterial thromboembolism but significantly higher rates of minor and major bleeding.